ChemPartner PharmaTech Co.,Ltd.

Equities

300149

CNE100000Y27

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 15/07/2024 BST			5-day change	1st Jan Change
3.92 ^CNY	-0.25%		+2.62%	-48.76%

06-24	ChemPartner PharmaTech Co.,Ltd.(XSEC:300149) dropped from S&P Global BMI Index	CI
04-25	Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Two Shanghai-based business management limited partnerships acquired additional unknown stake in Quantum Hi-Tech Biological Co., Ltd..

January 14, 2018

Two Shanghai-based business management limited partnerships acquired additional unknown stake in Quantum Hi-Tech (China) Biological Co., Ltd. (SZSE:300149) on January 15, 2018. Post the completion, the first business management limited partnership will own 8.9% stake and the second business management limited partnership will own 1.5% stake in in Quantum Hi-Tech (China) Biological Co., Ltd. Two Shanghai-based business management limited partnerships completed the acquisition of additional unknown stake in Quantum Hi-Tech (China) Biological Co., Ltd. (SZSE:300149) on January 15, 2018.

Latest news about ChemPartner PharmaTech Co.,Ltd.

ChemPartner PharmaTech Co.,Ltd.(XSEC:300149) dropped from S&P Global BMI Index	06-23	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-25	CI
Chempartner Pharmatech Announces Resolutions of the The First Extraordinary General Meeting of Shareholders 2024.	01-10	CI
MEGA STAR CENTRE LIMITED Announces Nominee to the Board of Chempartner Pharmatech.	12-29	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23	CI
ChemPartner PharmaTech CFO Steps Down	09/10/23	MT
ChemPartner PharmaTech Co.,Ltd.(XSEC:300149) added to S&P Global BMI Index	17/09/23	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23	CI
Chempartner Pharmatech Co., Ltd.(XSEC:300149) dropped from S&P Global BMI Index	19/12/22	CI
Chinese Shares End Mixed; ChemPartner Falls 6% as Chairman Assumes CEO Role	14/12/22	MT
ChemPartner PharmaTech Appoints Chairman as CEO; Shares Rise 4%	14/12/22	MT
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22	CI
Tate & Lyle Investments Limited completed the acquisition of Quantum Hi-Tech Biological Co., Ltd. from Chempartner Pharmatech Co., Ltd..	08/06/22	CI
Chempartner Pharmatech Co., Ltd. announced that it expects to receive CNY 300 million in funding	07/05/22	CI
Jiangmen Xinhui Hefeng Trading Co., Ltd. completed the acquisition of Quantum Hi-Tech Health Technology Co., Ltd from Chempartner Pharmatech Co., Ltd..	04/05/22	CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22	CI
Tate & Lyle To Pay $237 Million For Chinese Prebiotic Dietary Fiber Business	31/03/22	MT
Tate & Lyle Investments Limited agreed to acquire Quantum Hi-Tech Biological Co., Ltd. from Chempartner Pharmatech Co., Ltd. for CNY 1500 million.	30/03/22	CI
Porton Pharma Solutions Ltd. agreed to acquire Kaihui Pharmaceutical Co., Ltd. from Chempartner Pharmatech Co., Ltd. for CNY 241 million.	08/03/22	CI
Tranche Update on Chempartner Pharmatech Co., Ltd.'s Equity Buyback Plan announced on January 22, 2021.	21/01/22	CI
Chempartner Pharmatech Co., Ltd.'s Equity Buyback announced on January 22, 2021, has expired with 1,812,900 shares, representing 0.36% for CNY 25.5 million.	20/01/22	CI

Chart ChemPartner PharmaTech Co.,Ltd.

Duration

Period

More charts

Company Profile

ChemPartner PharmaTech Co Ltd, formerly Quantum Hi-tech China Biological Co Ltd, is a China-based company principally engaged in the research, development, production, and sales of fructooligosaccharides and other prebiotics. The Company's main products include fructooligosaccharides and galactooligosaccharides. The Company owns brands names of FOS and GOS. The Company's products are mainly used in nutrition and health products, dairy products, beverages, baked goods, functional candy and snack foods. The Company distributes its products mainly in domestic market, with South China as its main market.

Sector

Biotechnology & Medical Research

Calendar

29/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
CHEMPARTNER PHARMATECH CO.,LTD.	-48.76%	269M
MODERNA, INC.	+25.83%	47.96B
IQVIA HOLDINGS INC.	+0.69%	42.45B
LONZA GROUP AG	+44.53%	41.47B
ALNYLAM PHARMACEUTICALS, INC.	+30.52%	31.6B
ICON PUBLIC LIMITED COMPANY	+22.30%	28.63B
CELLTRION, INC.	-6.35%	28.03B
UNITED THERAPEUTICS CORPORATION	+49.25%	14.56B
MEDPACE HOLDINGS, INC.	+49.18%	14.14B
BIO-TECHNE CORPORATION	+3.45%	12.58B

Other Biotechnology & Medical Research